The restructuring is expected to enable both institutions to support larger ticket infrastructure financing and long-gestation development projects.
Business
M
Moneycontrol01-02-2026, 12:00

FM Sitharaman Unveils 'Biopharma Shakti' with Rs 10,000 Crore Boost for Pharma Sector

  • Finance Minister Nirmala Sitharaman announced a Rs 10,000 crore outlay over five years for "Biopharma Shakti" in Budget 2026.
  • The program aims to boost domestic production of biologics and biosimilars, reducing import dependence.
  • It includes creating a biopharma-focused institutional network with three new NIPERs and upgrading seven existing ones.
  • Focus areas are health advancement through knowledge, technology, and innovation, addressing non-communicable diseases.
  • Plans also include 1,000 accredited clinical trial sites and strengthening the Central Drug Standard Control Organisation.

Why It Matters: Biopharma Shakti will invest Rs 10,000 crore to make India a global biopharma manufacturing hub.

More like this

Loading more articles...